{"id":68823,"date":"2026-04-11T00:30:00","date_gmt":"2026-04-10T19:00:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=68823"},"modified":"2026-04-09T16:41:50","modified_gmt":"2026-04-09T11:11:50","slug":"healthcare-global-enterprises-q4-results-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/","title":{"rendered":"Healthcare Global Enterprises Q4 Results 2026: Date, Revenue, PAT And Analyst Outlook"},"content":{"rendered":"<p>Healthcare Global Enterprises (NSE: HCG) is preparing to announce its Q4 FY26 financial results for the period ended March 31, 2026. The board of directors is scheduled to meet on May 2026 (Expected) to approve the audited statements and consider a final dividend recommendation. With the stock trading at Rs 295 \u2014 against a 52-week high of Rs 395 and a 1-year return of -16% \u2014 the Q4 FY26 results will be a pivotal event for investors.<\/p><p>Analyst estimates for Q4 FY26 revenue stand at Rs 590-640 Cr, with PAT expectations of Rs 20-35 Cr and margin projections of EBITDA 18-20%. This article covers the Healthcare Global Enterprises Q4 results 2026 date, earnings estimates, five key performance factors, five risks, analyst ratings, and the most commonly searched investor questions.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Healthcare_Global_Enterprises_Q4_Results_2026_Date\" title=\"Healthcare Global Enterprises Q4 Results 2026 Date\">Healthcare Global Enterprises Q4 Results 2026 Date<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Why_This_Quarter_Matters\" title=\"Why This Quarter Matters\">Why This Quarter Matters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Healthcare_Global_Enterprises_Q4_FY26_Earnings_Estimates\" title=\"Healthcare Global Enterprises Q4 FY26 Earnings Estimates\">Healthcare Global Enterprises Q4 FY26 Earnings Estimates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#5_Key_Factors_That_Will_Drive_Healthcare_Global_Enterprises_Q4_FY26_Performance\" title=\"5 Key Factors That Will Drive Healthcare Global Enterprises Q4 FY26 Performance\">5 Key Factors That Will Drive Healthcare Global Enterprises Q4 FY26 Performance<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Revenue_Momentum\" title=\"Revenue Momentum\">Revenue Momentum<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Margin_Trajectory\" title=\"Margin Trajectory\">Margin Trajectory<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#PAT_Quality\" title=\"PAT Quality\">PAT Quality<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Management_Guidance_for_FY27\" title=\"Management Guidance for FY27\">Management Guidance for FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Dividend_Declaration\" title=\"Dividend Declaration\">Dividend Declaration<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#5_Risks_to_Watch_in_Healthcare_Global_Enterprises_Q4_FY26\" title=\"5 Risks to Watch in Healthcare Global Enterprises Q4 FY26\">5 Risks to Watch in Healthcare Global Enterprises Q4 FY26<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#US_Tariff_and_Macro_Headwinds\" title=\"US Tariff and Macro Headwinds\">US Tariff and Macro Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Earnings_Miss_Risk\" title=\"Earnings Miss Risk\">Earnings Miss Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#FY27_Guidance_Below_Consensus\" title=\"FY27 Guidance Below Consensus\">FY27 Guidance Below Consensus<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#FII_Outflow_Continuation\" title=\"FII Outflow Continuation\">FII Outflow Continuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Sector_Regulatory_Risk\" title=\"Sector Regulatory Risk\">Sector Regulatory Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Healthcare_Global_Enterprises_Share_Price_and_Analyst_Ratings\" title=\"Healthcare Global Enterprises Share Price and Analyst Ratings\">Healthcare Global Enterprises Share Price and Analyst Ratings<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#What_is_the_Healthcare_Global_Enterprises_Q4_results_2026_date\" title=\"What is the Healthcare Global Enterprises Q4 results 2026 date?\">What is the Healthcare Global Enterprises Q4 results 2026 date?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#What_is_the_Healthcare_Global_Enterprises_Q4_FY26_PAT_estimate\" title=\"What is the Healthcare Global Enterprises Q4 FY26 PAT estimate?\">What is the Healthcare Global Enterprises Q4 FY26 PAT estimate?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#What_is_Healthcare_Global_Enterprisess_share_price_ahead_of_Q4_results\" title=\"What is Healthcare Global Enterprises&#8217;s share price ahead of Q4 results?\">What is Healthcare Global Enterprises&#8217;s share price ahead of Q4 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Will_Healthcare_Global_Enterprises_declare_a_dividend_in_Q4_FY26\" title=\"Will Healthcare Global Enterprises declare a dividend in Q4 FY26?\">Will Healthcare Global Enterprises declare a dividend in Q4 FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Which_analysts_have_a_Buy_rating_on_Healthcare_Global_Enterprises\" title=\"Which analysts have a Buy rating on Healthcare Global Enterprises?\">Which analysts have a Buy rating on Healthcare Global Enterprises?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#What_were_Healthcare_Global_Enterprises_Q3_FY26_results\" title=\"What were Healthcare Global Enterprises Q3 FY26 results?\">What were Healthcare Global Enterprises Q3 FY26 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#When_do_Infosys_and_TCS_announce_Q4_results_2026\" title=\"When do Infosys and TCS announce Q4 results 2026?\">When do Infosys and TCS announce Q4 results 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Is_Healthcare_Global_Enterprises_a_good_investment_ahead_of_Q4_results\" title=\"Is Healthcare Global Enterprises a good investment ahead of Q4 results?\">Is Healthcare Global Enterprises a good investment ahead of Q4 results?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-global-enterprises-q4-results-2026\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Healthcare_Global_Enterprises_Q4_Results_2026_Date\"><\/span><strong>Healthcare Global Enterprises Q4 Results 2026 Date<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Get free investment predictions and live Q4 result alerts on <a href=\"https:\/\/univest.in\/user\/log-in\">Univest<\/a>.<\/p><p>Healthcare Global Enterprises has scheduled its Q4 FY26 results for May 2026 (Expected). Here is the broader Q4 FY26 earnings calendar:<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Company<\/strong><\/td><td><strong>Results Date<\/strong><\/td><td><strong>Article<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/stocks\/tcs\/tata-consultancy-services-ltd-share-price-today\">TCS<\/a><\/td><td>April 9, 2026<\/td><td>Preview on Univest<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/stocks\/infy\/infosys-ltd-share-price-today\">Infosys<\/a><\/td><td>April 23, 2026<\/td><td>Preview on Univest<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/stocks\/hcg\/healthcare-global-enterprises-ltd-share-price-today\">Healthcare Global Enterprises<\/a><\/td><td>May 2026 (Expected)<\/td><td>This article<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Why_This_Quarter_Matters\"><\/span><strong>Why This Quarter Matters<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Healthcare Global Enterprises enters Q4 FY26 with expectations of 12-16% YoY revenue growth. Q4 is the final quarter of FY26 \u2014 it determines full-year performance, sets FY27 estimate baselines, and triggers final dividend announcements. At a 1-year return of -16%, this quarter&#8217;s results and FY27 guidance will be critical in determining whether the stock can sustain recovery momentum.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Healthcare_Global_Enterprises_Q4_FY26_Earnings_Estimates\"><\/span><strong>Healthcare Global Enterprises Q4 FY26 Earnings Estimates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163826\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates-1024x536.jpg\" alt=\"Healthcare Global Enterprises Q4 FY26 analyst estimates. Source: MOFSL, YES Securities, JM Financial.\" class=\"wp-image-68832\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163826\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163826\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163826\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163826\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163826\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163826\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163826\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>Access premium SEBI-registered research on <a href=\"https:\/\/univest.in\/user\/log-in\">Univest<\/a>.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Metric<\/strong><\/td><td><strong>Q3 FY26 Actual<\/strong><\/td><td><strong>Q4 FY26 Estimate<\/strong><\/td><td><strong>Driver<\/strong><\/td><\/tr><tr><td>Revenue<\/td><td>Rs 540 Cr<\/td><td>Rs 590-640 Cr<\/td><td>Volume + pricing<\/td><\/tr><tr><td>PAT<\/td><td>Rs 14 Cr<\/td><td>Rs 20-35 Cr<\/td><td>Operating leverage<\/td><\/tr><tr><td>Margin<\/td><td>EBITDA 18.4%<\/td><td>EBITDA 18-20%<\/td><td>Cost control<\/td><\/tr><tr><td>Key Growth Metric<\/td><td>Q3 trend<\/td><td>12-16% YoY revenue growth<\/td><td>Management execution<\/td><\/tr><tr><td>Dividend Estimate<\/td><td>\u2014<\/td><td>Nil expected<\/td><td>Board recommendation<\/td><\/tr><\/tbody><\/table><\/figure><p>A positive surprise on any two of the four key parameters \u2014 revenue, margin, guidance, and dividend \u2014 could drive a meaningful post-results re-rating.<\/p><p>Screen <a href=\"https:\/\/univest.in\/screeners\">Healthcare Global Enterprises fundamentals<\/a> on <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_Key_Factors_That_Will_Drive_Healthcare_Global_Enterprises_Q4_FY26_Performance\"><\/span><strong>5 Key Factors That Will Drive Healthcare Global Enterprises Q4 FY26 Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Revenue_Momentum\"><\/span><strong>Revenue Momentum<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analysts expect Rs 590-640 Cr in Q4 FY26 revenue versus Rs 540 Cr in Q3. Q4 is seasonally important for the Healthcare sector. The ability to convert the pipeline into recognised revenue will be the first performance test investors focus on when results are declared.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Margin_Trajectory\"><\/span><strong>Margin Trajectory<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Q4 FY26 margin expectations are EBITDA 18-20% versus EBITDA 18.4% in Q3. Input cost trends, employee expenses, and pricing power will determine whether the company can sustain or improve on Q3 levels. Any margin beat would be a significant positive catalyst for the stock.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"PAT_Quality\"><\/span><strong>PAT Quality<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Net profit is estimated at Rs 20-35 Cr. Investors will closely assess whether PAT is driven by operational improvement or non-recurring items. A clean, recurring profit print is most positively received by institutional investors tracking the stock.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Management_Guidance_for_FY27\"><\/span><strong>Management Guidance for FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The most consequential output will be FY27 guidance \u2014 revenue growth bands, margin targets, and capex plans. In the current global macro environment, credible and specific FY27 guidance will be valued more than usual by the market.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dividend_Declaration\"><\/span><strong>Dividend Declaration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Healthcare Global Enterprises is expected to consider a final dividend of Nil expected. The quantum signals management&#8217;s confidence in free cash flow generation and sets expectations for FY27 capital allocation strategy.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_Risks_to_Watch_in_Healthcare_Global_Enterprises_Q4_FY26\"><\/span><strong>5 Risks to Watch in Healthcare Global Enterprises Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"US_Tariff_and_Macro_Headwinds\"><\/span><strong>US Tariff and Macro Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The 26% US reciprocal tariff on Indian goods has created macro uncertainty across all Indian equities. For Healthcare Global Enterprises, indirect impacts include FII outflows and potential earnings estimate cuts if global demand slows. Progress in India-US trade negotiations remains the most important macro catalyst.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Earnings_Miss_Risk\"><\/span><strong>Earnings Miss Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>If Healthcare Global Enterprises&#8217;s Q4 FY26 results miss estimates, the stock could correct sharply regardless of longer-term fundamentals. Investors should monitor revenue versus the Rs 590-640 Cr estimate and PAT versus Rs 20-35 Cr as the two primary watchpoints.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FY27_Guidance_Below_Consensus\"><\/span><strong>FY27 Guidance Below Consensus<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>If FY27 guidance falls below Street expectations, the stock may decline even if Q4 numbers are in line. In the current environment, forward guidance carries more weight than the reported quarter.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FII_Outflow_Continuation\"><\/span><strong>FII Outflow Continuation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>FIIs sold Rs 22,000 crore in Indian equities in a single week following the tariff announcement. Continued selling pressure would create headwinds for Healthcare Global Enterprises regardless of company-specific fundamentals.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sector_Regulatory_Risk\"><\/span><strong>Sector Regulatory Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The Healthcare sector faces evolving regulatory frameworks. Any policy changes that increase compliance costs or alter competitive dynamics could affect Healthcare Global Enterprises&#8217;s profitability beyond current consensus models.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Healthcare_Global_Enterprises_Share_Price_and_Analyst_Ratings\"><\/span><strong>Healthcare Global Enterprises Share Price and Analyst Ratings<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163922\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings-1024x536.jpg\" alt=\"Healthcare Global Enterprises share price snapshot and analyst ratings. Source: Brokerages, NSE data.\" class=\"wp-image-68837\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163922\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163922\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163922\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163922\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163922\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163922\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163922\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>Healthcare Global Enterprises is trading at Rs 295 as of early April 2026, against a 52-week high of Rs 395 and a 52-week low of Rs 235. Market cap stands at Rs 4,000 Cr. The 1-year return of -16% reflects sector headwinds alongside company-specific factors.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Brokerage<\/strong><\/td><td><strong>Rating<\/strong><\/td><td><strong>Target Price<\/strong><\/td><td><strong>Thesis<\/strong><\/td><\/tr><tr><td>MOFSL<\/td><td>Buy<\/td><td>Rs 380<\/td><td>Oncology hospital network; KKR-backed<\/td><\/tr><tr><td>YES Securities<\/td><td>Buy<\/td><td>Rs 375<\/td><td>Tier-2 city cancer care expansion<\/td><\/tr><tr><td>JM Financial<\/td><td>Add<\/td><td>Rs 360<\/td><td>Occupancy + ARPOB growing steadily<\/td><\/tr><tr><td>Emkay<\/td><td>Buy<\/td><td>Rs 365<\/td><td>Best cancer care franchise India<\/td><\/tr><\/tbody><\/table><\/figure><p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Healthcare Global Enterprises&#8217;s live price and receive real-time Q4 result alerts.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Healthcare Global Enterprises Q4 FY26 results on May 2026 (Expected) will be a key event for investors monitoring the Healthcare sector. Analysts project PAT of Rs 20-35 Cr and revenue of Rs 590-640 Cr. At a CMP of Rs 295 and analyst targets ranging from Rs 365 to Rs 380, the stock offers meaningful risk-reward for informed investors. FY27 guidance will be the most critical post-results catalyst.<\/p><p>For more Q4 FY26 previews across sectors, visit <a href=\"https:\/\/univest.in\/blogs\">Univest Blogs<\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_Healthcare_Global_Enterprises_Q4_results_2026_date\"><\/span><strong>What is the Healthcare Global Enterprises Q4 results 2026 date?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The Healthcare Global Enterprises Q4 results 2026 date is May 2026 (Expected). The board will meet to approve audited Q4 FY26 financials and consider a dividend recommendation for FY26.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_Healthcare_Global_Enterprises_Q4_FY26_PAT_estimate\"><\/span><strong>What is the Healthcare Global Enterprises Q4 FY26 PAT estimate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analysts estimate Healthcare Global Enterprises Q4 FY26 PAT at Rs 20-35 Cr, based on revenue of Rs 590-640 Cr and margin of EBITDA 18-20%. Actual results may differ from consensus estimates.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_Healthcare_Global_Enterprisess_share_price_ahead_of_Q4_results\"><\/span><strong>What is Healthcare Global Enterprises&#8217;s share price ahead of Q4 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Healthcare Global Enterprises is trading at Rs 295. The 52-week high is Rs 395 and low is Rs 235. The 1-year return is -16% and market cap is Rs 4,000 Cr.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Will_Healthcare_Global_Enterprises_declare_a_dividend_in_Q4_FY26\"><\/span><strong>Will Healthcare Global Enterprises declare a dividend in Q4 FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Healthcare Global Enterprises is expected to consider a final dividend of Nil expected at the Q4 FY26 board meeting on May 2026 (Expected).<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Which_analysts_have_a_Buy_rating_on_Healthcare_Global_Enterprises\"><\/span><strong>Which analysts have a Buy rating on Healthcare Global Enterprises?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>MOFSL (Buy, Rs 380), YES Securities (Buy, Rs 375), JM Financial (Add, Rs 360), Emkay (Buy, Rs 365) have positive ratings heading into Q4 FY26.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_were_Healthcare_Global_Enterprises_Q3_FY26_results\"><\/span><strong>What were Healthcare Global Enterprises Q3 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Healthcare Global Enterprises reported Q3 FY26 revenue of Rs 540 Cr and PAT of Rs 14 Cr, with margin at EBITDA 18.4%. These form the baseline for Q4 FY26 consensus estimates.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"When_do_Infosys_and_TCS_announce_Q4_results_2026\"><\/span><strong>When do Infosys and TCS announce Q4 results 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>TCS declared Q4 FY26 results on April 9, 2026. Read the TCS Q4 Results 2026 preview on Univest Blogs. Infosys Q4 FY26 results are scheduled for April 23, 2026. Read the Infosys Q4 Results 2026 preview on Univest Blogs.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Is_Healthcare_Global_Enterprises_a_good_investment_ahead_of_Q4_results\"><\/span><strong>Is Healthcare Global Enterprises a good investment ahead of Q4 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>This depends on your risk appetite and portfolio context. Healthcare Global Enterprises has compelling long-term factors alongside genuine near-term risks. Consult a SEBI-registered financial advisor before making any investment decision.<\/p><p><strong>Disclaimer: <\/strong>Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/tcs-share-price-target\">TCS Share Price Target 2026 \u2014 Key Factors, Financial Performance &amp; Analyst Forecast<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/nestle-india-share-price-target\">Nestle India Share Price Target 2026 \u2014 Key Factors, Financial Performance &amp; Analyst Forecast<\/a><\/p><p><a href=\"http:\/\/univest.in\/blogs\/state-bank-of-india-share-price-target\">State Bank of India Share Price Target 2026: Analyst Forecasts, Bull &amp; Bear Case<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/hindustan-unilever-share-price-target\">Hindustan Unilever Share Price Target 2026 \u2014 Key Factors, Financial Performance &amp; Analyst Forecast<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Healthcare Global Enterprises (NSE: HCG) is preparing to announce its Q4 FY26 financial results for the period ended March 31, 2026. The board of directors is scheduled to meet on May 2026 (Expected) to approve the audited statements and consider a final dividend recommendation. With the stock trading at Rs 295 \u2014 against a 52-week<\/p>\n","protected":false},"author":23,"featured_media":68829,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3983],"class_list":["post-68823","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-q4-results-2026"],"metadata":{"_edit_lock":["1775733148:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:10:{s:62:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/image-431.jpeg\";a:2:{s:2:\"id\";i:68826;s:11:\"source_type\";s:13:\"media-library\";}s:94:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163332\/image-431.jpeg\";a:2:{s:2:\"id\";i:68826;s:11:\"source_type\";s:13:\"media-library\";}s:108:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates.jpg\";a:2:{s:2:\"id\";i:68832;s:11:\"source_type\";s:13:\"media-library\";}s:117:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates-1024x536.jpg\";a:2:{s:2:\"id\";i:68832;s:11:\"source_type\";s:13:\"media-library\";}s:140:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163826\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates.jpg\";a:2:{s:2:\"id\";i:68832;s:11:\"source_type\";s:13:\"media-library\";}s:149:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163826\/Healthcare-Global-Enterprises-Q4-FY26-Earnings-Estimates-1024x536.jpg\";a:2:{s:2:\"id\";i:68832;s:11:\"source_type\";s:13:\"media-library\";}s:113:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings.jpg\";a:2:{s:2:\"id\";i:68837;s:11:\"source_type\";s:13:\"media-library\";}s:122:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings-1024x536.jpg\";a:2:{s:2:\"id\";i:68837;s:11:\"source_type\";s:13:\"media-library\";}s:145:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163922\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings.jpg\";a:2:{s:2:\"id\";i:68837;s:11:\"source_type\";s:13:\"media-library\";}s:154:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163922\/Healthcare-Global-Enterprises-Share-Price-and-Analyst-Ratings-1024x536.jpg\";a:2:{s:2:\"id\";i:68837;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["842"],"rank_math_seo_score":["86"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"rank_math_title":["Healthcare Global Enterprises Q4 Results 2026: Date, Revenue, PAT And Analyst Outlook"],"rank_math_description":["Healthcare Global Enterprises Q4 results May 2026 (Expected). PAT estimate Rs 20-35 Cr, margin EBITDA 18-20%. Full Q4 FY26 preview with analyst targets and FY27 guidance watch.\n"],"rank_math_focus_keyword":["Healthcare Global Enterprises"],"_thumbnail_id":["68829"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/09163415\/Healthcare-Global-Enterprises-Q4-Results-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/68823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=68823"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/68823\/revisions"}],"predecessor-version":[{"id":68841,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/68823\/revisions\/68841"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/68829"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=68823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=68823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=68823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}